Key points are not available for this paper at this time.
Abstract The metabolism of 3‐chloromethcathinone (3‐CMC) was studied after controlled administration in a murine model using the dried blood spot (DBS) technique for the sampling, storage and purification of blood samples. Liquid chromatography–high‐resolution mass spectrometry (LC‐HRMS) was used for the identification of metabolites and investigation of their fragmentation pattern. Subsequently, a liquid chromatography–tandem mass spectrometry (LC‐MS/MS) method was developed for their identification and 3‐CMC quantification in routine workload. The main metabolites identified were two stereoisomers of dihydro‐CMC, N ‐demethyl‐CMC, and dihydro‐ N ‐demethyl‐CMC. The stability of 3‐CMC and of its metabolites deposited on DBS was evaluated by replicate analyses after 30, 50, and 90 days, demonstrating a decrease in concentration. It was more pronounced for 3‐CMC, with −67% and −82% percentage deviation from the initial concentrations, and for N ‐demethyl 3‐CMC (decrease comprised between −48% and −88%) than for the di‐hydro metabolites, ranging from −5% to −37%. Regardless, all of them were detectable till 90 days after deposition as DBS. The possibility of identifying 3‐CMC and its metabolites with high sensitivity is an invaluable tool for the diagnosis of exposure to the substance, also in low doses or after some hours, and for various applications in clinical and forensic toxicology, such as driving under the influence, drug‐facilitated crimes, and addiction to intoxications. DBS demonstrated to be a reliable technique for the sampling, storage, and purification of the blood specimen for 3‐CMC and metabolite detection.
Mestria et al. (2024) studied this question.